JP2012526543A5 - - Google Patents

Download PDF

Info

Publication number
JP2012526543A5
JP2012526543A5 JP2012510422A JP2012510422A JP2012526543A5 JP 2012526543 A5 JP2012526543 A5 JP 2012526543A5 JP 2012510422 A JP2012510422 A JP 2012510422A JP 2012510422 A JP2012510422 A JP 2012510422A JP 2012526543 A5 JP2012526543 A5 JP 2012526543A5
Authority
JP
Japan
Prior art keywords
pde9a
expression
sample
prostate cancer
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012510422A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012526543A (ja
JP5918694B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/052069 external-priority patent/WO2010131193A1/en
Publication of JP2012526543A publication Critical patent/JP2012526543A/ja
Publication of JP2012526543A5 publication Critical patent/JP2012526543A5/ja
Application granted granted Critical
Publication of JP5918694B2 publication Critical patent/JP5918694B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012510422A 2009-05-12 2010-05-11 前立腺がんのマーカーとしてのホスホジエステラーゼ９ａ Active JP5918694B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09159957.1 2009-05-12
EP09159957 2009-05-12
PCT/IB2010/052069 WO2010131193A1 (en) 2009-05-12 2010-05-11 Phosphodiesterase 9a as prostate cancer marker

Publications (3)

Publication Number Publication Date
JP2012526543A JP2012526543A (ja) 2012-11-01
JP2012526543A5 true JP2012526543A5 (enExample) 2013-06-27
JP5918694B2 JP5918694B2 (ja) 2016-05-18

Family

ID=40847939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012510422A Active JP5918694B2 (ja) 2009-05-12 2010-05-11 前立腺がんのマーカーとしてのホスホジエステラーゼ９ａ

Country Status (8)

Country Link
US (1) US9828604B2 (enExample)
EP (1) EP2430189B1 (enExample)
JP (1) JP5918694B2 (enExample)
KR (1) KR101695866B1 (enExample)
CN (1) CN102459645B (enExample)
BR (1) BRPI1007620A2 (enExample)
RU (1) RU2592668C2 (enExample)
WO (1) WO2010131193A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101675664B1 (ko) 2015-01-30 2016-11-11 경희대학교 산학협력단 전립선암 예방 또는 치료용 조성물
EP3303616B1 (en) 2015-05-29 2021-01-06 Koninklijke Philips N.V. Methods of prostate cancer prognosis
KR20180085387A (ko) 2016-12-27 2018-07-27 경희대학교 산학협력단 Trail 저항성 암 예방 또는 치료용 조성물
CN107119124B (zh) * 2017-05-10 2021-05-11 清华大学 一种检测待测样本中目标miRNA的含量的方法
KR102080887B1 (ko) * 2017-11-07 2020-02-24 고려대학교 산학협력단 Gcc2 유전자 또는 단백질을 과발현하는 엑소좀 기반 폐암 진단 또는 예후 예측용 마커 조성물
CN114349857B (zh) * 2022-03-15 2022-05-24 诺赛联合(北京)生物医学科技有限公司 一种Treg细胞制备方法以及在自身免疫性疾病方面的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922595A (en) * 1997-12-09 1999-07-13 Incyte Pharmaceuticals, Inc. Cyclic GMP phosphodiesterase
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
AU2003301894A1 (en) 2002-11-08 2004-06-07 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d)
WO2004053494A1 (en) * 2002-12-09 2004-06-24 Bayer Healthcare Ag DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)
AU2003288171A1 (en) * 2002-12-09 2004-06-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3)
AU2003289894A1 (en) * 2002-12-09 2004-06-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)
AU2003283427A1 (en) 2002-12-09 2004-06-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
US7405237B2 (en) 2004-07-28 2008-07-29 Celgene Corporation Isoindoline compounds and methods of their use
EP2074225B1 (en) 2006-10-10 2014-12-03 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Prostate cancer-specific alterations in erg gene expression and detection and treatment methods based on those alterations

Similar Documents

Publication Publication Date Title
JP2012526544A5 (enExample)
JP2017184729A5 (enExample)
RU2011150279A (ru) Фосфодиэстераза 4d7 как маркер рака предстательной железы
KR20170130441A (ko) 암 진단용 바이오마커 패널
US10613090B2 (en) Methods of detecting cancer
EP2529223A1 (en) Biomarkers for circulating tumor cells
Xu et al. Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma
US20130210667A1 (en) Biomarkers for Predicting Kidney and Glomerular Pathologies
JP6612414B2 (ja) Ｐｄ−ｌ１に対するｓｒｍアッセイ
CA3116552A1 (en) Methods for the treatment of solid tumor cancers using illudins and biomarkers
WO2015158652A2 (en) New biomarkers for metastatic breast cancer
JP2012526543A5 (enExample)
AU2017301970A1 (en) Combination test for colorectal cancer
JP2012520469A (ja) 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
WO2014198995A1 (es) Biomarcadores para el diagnóstico y respuesta al tratamiento en cáncer de páncreas
CN110702917B (zh) 血清淀粉样蛋白p在制备抑郁症诊断治疗相关产品的用途
RU2011150291A (ru) Фосфодиэстераза-9а в качестве маркера злокачественной опухоли предстательной железы
JP5568807B2 (ja) プロテオミクス解析を用いたメラノーママーカーの同定
JP2013213774A (ja) 結核検査用バイオマーカー
JP2021170021A (ja) 糖尿病性腎症の早期病態の特異的な診断を可能とする検査方法
KR102026252B1 (ko) 폐 편평상피세포암 바이오마커 및 이를 이용한 폐 편평상피세포암 진단방법
EP2895863B1 (en) New biomarkers for the diagnosis and/or prognosis of clear cell renal cell carcinoma
JP6691337B2 (ja) 膀胱癌患者の予後を予測するための方法
KR20140109956A (ko) 테나신-c 및 류마티스 관절염에서의 이의 용도
EP2876442A1 (en) Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast cancer